"It's really hard to envision extraordinary outcomes unless you do unreasonable-seeming things." In a new @business feature, Flagship Founder & CEO @NoubarAfeyan reflects on Flagship’s approach to company creation: pursuing ambitious scientific questions early, building the capabilities to test them, and creating companies around discoveries that can reshape what is possible. It's the approach that's led to over 130 companies, including #FlagshipFounded# @moderna_tx, @generate_biomed, @SailBiomeds, and more. #BiggerLeaps# Read the full story here:

Today, #FlagshipFounded# @moderna_tx, along with @Merck released positive results from its Phase 3 INTerpath-001 study for intismeran autogene, an investigational mRNA-based individualized neoantigen therapy, plus KEYTRUDA®, in patients with completely resected stage IIB-IV melanoma. 
Data will be presented at the 2026 European Society for Medical Oncology (@myESMO) Congress. #BiggerLeaps#

Today, Flagship launches Pioneering Abundance—a new initiative focused on reimagining how we produce the resources that power our world. For decades, we’ve built around the constraints of scarcity. Now, biology, AI, and deep tech are opening a different path: creating abundance. Learn more: #BiggerLeaps#